Concepedia

Author

P. Orfanos

Roche (Switzerland)

Also Known As

Orfanos, P., P Orfanos, P. Orfanos, Panagiotis Orfanos, Panos Orfanos, panagiotis Orfanos

47

Publications

128

Citations

4

H-Index

5

Concepts

All Affiliations

Roche (Switzerland)
PO

About

P. Orfanos is an author at Roche (Switzerland) specializing in cancer therapeutics, lung cancer, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

34

2

Pathology

1

1

34

3

Cancer Therapeutics

1

1

34

4

Lung Cancer

1

1

34

5

Oncology

1

1

34

P. Orfanos

×

3

Publications

103

Citations

3

H-Index

YearCitations

Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis

Arndt Vogel, Lorenza Rimassa, Hui-Chan Sun,

Liver Cancer

2021

52

Cost Effectiveness of Alectinib vs. Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer

Josh J. Carlson, Kangho Suh, P. Orfanos,

PharmacoEconomics

2018

34

Safety and Efficacy of CD37-Targeting Naratuximab Emtansine PLUS Rituximab in Diffuse Large B-Cell Lymphoma and Other NON-Hodgkin'S B-Cell Lymphomas - a Phase 2 Study

Moshe Levy, Deepa Jagadeesh, Marek Trněný,

Blood

2021

17

Page 1